Direct, programmable detection of epigenetic DNA cytosine modifications using TAL effectors

• US 9,879,315 B2
• Filed: 06/26/2014
• Issued: 01/30/2018
• Est. Priority Date: 06/26/2013
• Status: Active Grant

• Current Assignee: Universitã¤T Konstanz
• Original Assignee: Universitã¤T Konstanz
• Inventors: Summerer, Daniel, Kubik, M. Grzegorz, Schmidt, Moritz Johannes
• Primary Examiner(s): Dauner, Joseph G.
• Application Number:
  US14/899,483
• Publication Number:
  US 20160138094A1
• Time in Patent Office: 1,314 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 2522/101 Single or double stranded nucleic acid binding proteins
• CPC Class Codes: C12Q 2537/164 Methylation detection other then bisulfite or methylation sensitive restriction endonucleases

Abstract

Methods for the differentiation of a 5-hydroxymethyl modification of a cytosine residue of interest in a nucleic acid molecule from (i) a 5-methyl modification of the cytosine residue of interest or (ii) an unmodified cytosine residue of interest, the methods making use of the capability of transcription-activator-like effector (TALE) proteins to preferentially bind with strong affinity to nucleic acid sequences containing non-modified cytosine residues or 5-methyl modified cytosine residues, and to bind, if at all, with only strongly reduced affinity to nucleic acid sequences containing 5-hydroxymethyl modified cytosine residues. The present invention further relates to respective uses of TALE proteins for the differentiation of a 5-hydroxymethyl modification of a cytosine residue of interest in a nucleic acid molecule from (i) a 5-methyl modification of the cytosine residue of interest or (ii) the unmodified cytosine residue of interest.

Claims

1. A method for the differentiation of a 5-hydroxymethyl modification of a cytosine residue of interest in a nucleic acid molecule from

(i) a 5-methyl modification of said cytosine residue of interest or

(ii) an unmodified cytosine residue of interest,

said method comprising the steps of:

(a) providing a transcription-activator-like effector (TALE) protein, said TALE protein being capable of binding in a sequence- and locus- specific manner to a region of said nucleic acid molecule that includes said cytosine residue of interest, wherein a repeat variable diresidue (RVD) of said TALE protein whose position corresponds to the position of the cytosine residue of interest is a size reduced RVD; and

(b) determining whether said TALE protein binds to said region by

detecting a 5-hydroxymethyl modification of said cytosine residue of interest, wherein

(i) said modification is present when said TALE protein does not bind to said region or does bind to said region with a strongly reduced affinity, and

(ii) said modification is absent when said TALE protein binds to said region,

said method allowing for the direct detection of a 5-hydroxymethyl modification of said cytosine residue of interest in said nucleic acid molecule.

2. The method of claim 1, wherein the repeat variable diresidue (RVD) of said TALE protein whose position corresponds to the position of the cytosine residue of interest is the RVD H* or the RVD N*.

3. The method of claim 1, wherein step (b) comprises the step of determining whether a specific DNA polymerase reaction using a primer that is capable of binding to the region of said nucleic acid molecule that includes said cytosine residue of interest is inhibited, thus indicating binding of said TALE protein to said region, said method allowing for the direct detection of a 5-hydroxymethyl modification of said cytosine residue of interest in said nucleic acid molecule.

4. The method of claim 3, wherein step (b) comprises the steps of:

(b1) providing a primer that is capable of binding to the region of said nucleic acid molecule that includes said cytosine residue of interest;

(b2) adding said TALE protein to a first aliquot of the nucleic acid molecule;

(b3) performing a first specific DNA polymerase reaction with said primer using said first aliquot of the nucleic acid molecule as template, and performing a second specific DNA polymerase reaction with said primer using a second aliquot of the nucleic acid molecule as template to which no TALE protein has been added;

(b4) determining at least one parameter, selected from the group consisting of the concentration, size, and sequence of each of the products of said first and second specific DNA polymerase reaction; and

(b5) determining whether said TALE protein binds to said region, wherein (i) said TALE protein does not bind to said region or does bind to said region with a strongly reduced affinity when the parameter determined in step (b4) for the first specific DNA polymerase reaction does not differ significantly from the parameter detected in step (b4) for the second specific DNA polymerase reaction, and (ii) said TALE protein binds to said region when the parameter detected in step (b4) for the first specific DNA polymerase reaction differs significantly from the parameter detected in step (b4) for the second specific DNA polymerase reaction.

5. The method of claim 4, wherein in step (b4)

(i) the concentration of the products of said first and second specific DNA polymerase reaction is determined using a method, selected from the group consisting quantitative polymerase chain reaction (qPCR), fluorescence measurements using nucleic acid binding fluorescent probes, and photometry;

and/or

(ii) the size of the products of said first and second specific DNA polymerase reaction is determined using a method, selected from the group consisting of polymerase chain reaction (PCR), and gel electrophoresis; and

/or

(iii) the sequence of the products of said first and second specific DNA polymerase reaction is determined using a method, selected from the group consisting of Sanger sequencing, pyrosequencing, microarray hybridization, next-generation sequencing methods, and next-next-generation sequencing methods.

6. The method of claim 4, further comprising the steps of:

(d) comparing the parameter detected in step (b4) for the first specific DNA polymerase reaction to one or more respective parameters obtained from nucleic acid molecules having a known degree of modification of the cytosine residue of interest; and

(e) thereby determining the degree of modification of the cytosine residue of interest in the nucleic acid molecule.

7. The method of claim 1, wherein the TALE protein is coupled directly or indirectly to an affinity ligand, said method further comprising the step of:

(c) depleting nucleic acid molecules in which a 5-methyl modification of said cytosine residue of interest or said unmodified cytosine residue of interest is present via affinity chromatography using said affinity ligand;

said method allowing for the enrichment of nucleic acid molecules in which a 5-hydroxymethyl modification of said cytosine residue of interest is present.

8. The method of claim 1, wherein the TALE protein is coupled directly or indirectly to a protein having nuclease activity, said method further comprising the step of:

(c) digesting nucleic acid molecules in which a 5-methyl modification of said cytosine residue of interest or said unmodified cytosine residue of interest is present using said protein having nuclease activity;

said method allowing for the differential digestion of nucleic acid molecules in which a 5-methyl modification of said cytosine residue of interest or said unmodified cytosine residue of interest is present, wherein nucleic acid molecules in which a 5-hydroxymethyl modification of said cytosine residue of interest is present remain undigested.